AstraZeneca Pushes for Mandatory FDA Review of DTC Ads

Drug Industry Daily
KEYWORDS Advertising / FDA
A A

Saying PhRMA's voluntary code of conduct doesn't go far enough, AstraZeneca has proposed that drugmakers submit to mandatory FDA review of all direct-to-consumer (DTC) advertisements prior to use.

To View This Article:

Login

Subscribe To Drug Industry Daily